Pál Kiss Selected Research

gadolinium N- (2- butyryloxyethyl)- N'- (2- ethyloxyethyl)- N,N'- bis(N'',N''- bis(carboxymethyl)acetamido)- 1,2- ethanediamine

12/2008	Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.
7/2007	In vivo myocardial tissue kinetics of Gd(ABE-DTTA), a tissue-persistent contrast agent.
6/2007	Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pál Kiss Research Topics

Disease

4	Infarction (Infarctions) 10/2010 - 07/2007
3	Myocardial Infarction 07/2007 - 01/2006

Drug/Important Bio-Agent (IBA)

3	gadolinium N- (2- butyryloxyethyl)- N'- (2- ethyloxyethyl)- N,N'- bis(N'',N''- bis(carboxymethyl)acetamido)- 1,2- ethanediamineIBA 12/2008 - 06/2007
2	Gadolinium DTPA (Magnevist)FDA Link 10/2010 - 12/2008
2	Contrast MediaIBA 06/2007 - 01/2006
1	Hematoxylin (Haematoxylon)IBA 01/2008
1	ChloridesIBA 01/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2008
1	Isoflurane FDA LinkGeneric 01/2006

Therapy/Procedure

1	Catheters 07/2007
1	Anesthesia 01/2006